These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26861241)

  • 1. Effects of the enlargement of polyglutamine segments on the structure and folding of ataxin-2 and ataxin-3 proteins.
    Wen J; Scoles DR; Facelli JC
    J Biomol Struct Dyn; 2017 Feb; 35(3):504-519. PubMed ID: 26861241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional analysis of ataxin-2 and ataxin-3.
    Albrecht M; Golatta M; Wüllner U; Lengauer T
    Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modeling of ataxin-3 reveals distant homology to adaptins.
    Albrecht M; Hoffmann D; Evert BO; Schmitt I; Wüllner U; Lengauer T
    Proteins; 2003 Feb; 50(2):355-70. PubMed ID: 12486728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion.
    Scarff CA; Almeida B; Fraga J; Macedo-Ribeiro S; Radford SE; Ashcroft AE
    Mol Cell Proteomics; 2015 May; 14(5):1241-53. PubMed ID: 25700012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced molecular mobility of ordinarily structured regions drives polyglutamine disease.
    Lupton CJ; Steer DL; Wintrode PL; Bottomley SP; Hughes VA; Ellisdon AM
    J Biol Chem; 2015 Oct; 290(40):24190-200. PubMed ID: 26260925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation Based Investigation of Deleterious nsSNPs in ATXN2 Gene and Its Structural Consequence Toward Spinocerebellar Ataxia.
    Sinha S; Verma S; Singh A; Somvanshi P; Grover A
    J Cell Biochem; 2018 Jan; 119(1):499-510. PubMed ID: 28612427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation.
    Johnson SL; Ranxhi B; Libohova K; Tsou WL; Todi SV
    Elife; 2020 Sep; 9():. PubMed ID: 32955441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
    Li X; Liu H; Fischhaber PL; Tang TS
    Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using
    Sousa E Silva R; Sousa AD; Vieira J; Vieira CP
    Front Mol Neurosci; 2023; 16():1140719. PubMed ID: 37008788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.
    Chai Y; Berke SS; Cohen RE; Paulson HL
    J Biol Chem; 2004 Jan; 279(5):3605-11. PubMed ID: 14602712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capturing the Conformational Ensemble of the Mixed Folded Polyglutamine Protein Ataxin-3.
    Sicorello A; Różycki B; Konarev PV; Svergun DI; Pastore A
    Structure; 2021 Jan; 29(1):70-81.e5. PubMed ID: 33065068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families].
    Tang B; Wang D; Xia J
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):819-22. PubMed ID: 9772474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic prospects for spinocerebellar ataxia type 2 and 3.
    Bezprozvanny I; Klockgether T
    Drugs Future; 2009 Dec; 34(12):. PubMed ID: 26023252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils.
    Bevivino AE; Loll PJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11955-60. PubMed ID: 11572942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of the AXH domain of spinocerebellar ataxin-1.
    Chen YW; Allen MD; Veprintsev DB; Löwe J; Bycroft M
    J Biol Chem; 2004 Jan; 279(5):3758-65. PubMed ID: 14583607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
    Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
    J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
    Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.